Evidence map›Paper›PMID 37578525›Full record

ArticlePsychopharmacology2023

Characterization of behavioral changes in T-maze alternation from dopamine D

Jack X Cimino, Mi Zhou, James Waxmonsky, Richard B Mailman, Yang Yang

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Concomitant activation of DResearch square · 2026
    Article
  3. Concomitant activation of DDiscover pharmaceutical sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Dopamine DNeuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jack X CiminoNeuroscience Program, Penn State University College of Medicine, Hershey, PA, 17033, USA.
Mi ZhouDepartment of Pharmacology, Penn State University College of Medicine, Hershey, PA, 17033, USA.
James WaxmonskyDepartment of Psychiatry and Behavioral Health, Penn State University College of Medicine, Hershey, PA, 17033, USA.
Richard B MailmanDepartment of Pharmacology, Penn State University College of Medicine, Hershey, PA, 17033, USA.
Yang YangDepartment of Pharmacology, Penn State University College of Medicine, Hershey, PA, 17033, USA. yangyang@psu.edu.ORCID http://orcid.org/0000-0001-6612-8865
Pennsylvania State University · US

Funding

Discovery of functionally selective dopamine ligands for age-related cognitive declineRF1AG071675 · NIA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI DOKHOLYAN, NIKOLAY, MAILMAN, RICHARD B · 2021 to 2021
$1.5M
In vivo agonist molecular probes for the dopamine D1 receptorR01NS105471 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MAILMAN, RICHARD B, SHARMA, ARUN K · 2018 to 2020
$1.0M
Discovery of functionally selective dopamine ligands for age-related cognitive declineR01AG071675 · NIA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI DOKHOLYAN, NIKOLAY, MAILMAN, RICHARD B · 2024 to 2025
$968k
NIA NIH HHS R01 AG071675NIA NIH HHS RF1 AG071675NINDS NIH HHS R01 NS105471
6 · The paper itself

Abstract

rationaleDopamine D OBJECTIVES AND

methodsTo test this hypothesis, we compared two D

resultsBoth D

conclusionsThese data suggest that D

Indexed as

DopamineDopamine Agonistsbeta-ArrestinsLigandsMaze LearningReceptors, Dopamine D1beta-ArrestinsDopamineDopamine AgonistsLigandsReceptors, Dopamine D1Dopamine D1 agonistFunctional selectivity/signaling biasRodent T-maze alternationSpatial working memory

Identifiers

PMID37578525
PMCPMC10693963
OpenAlexW4385798056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.